XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment from adoption of new accounting pronouncement
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative-effect adjustment from adoption of new accounting pronouncement
Accumulated Other Comprehensive Loss
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative-effect adjustment from adoption of new accounting pronouncement
Beginning balance (in shares) at Dec. 31, 2020     162,709,720            
Beginning balance at Dec. 31, 2020 $ 4,251,296   $ 1,627 $ 3,664,820   $ (20,201) $ 0 $ 605,050  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     1,665,123            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (88,747)   $ 16 (88,763)          
Issuance of common stock under employee stock purchase plan (in shares)     358,384            
Issuance of common stock under employee stock purchase plan 31,531   $ 4 31,527          
Stock-based compensation 182,039     182,039          
Repurchases of common stock (in shares)     (2,308,787)            
Repurchases of common stock (251,257)           (251,257)    
Net income 491,108             491,108  
Foreign currency translation adjustments (28,444)         (28,444)      
Change in unrealized loss on investments, net of tax (5,081)         (5,081)      
Ending balance (in shares) at Sep. 30, 2021     162,424,440            
Ending balance at Sep. 30, 2021 4,582,445   $ 1,647 3,789,623   (53,726) (251,257) 1,096,158  
Beginning balance (in shares) at Jun. 30, 2021     163,018,768            
Beginning balance at Jun. 30, 2021 4,476,657   $ 1,645 3,743,743   (31,557) (154,416) 917,242  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     252,204            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (11,866)   $ 2 (11,868)          
Stock-based compensation 57,748     57,748          
Repurchases of common stock (in shares)     (846,532)            
Repurchases of common stock (96,841)           (96,841)    
Net income 178,916             178,916  
Foreign currency translation adjustments (21,160)         (21,160)      
Change in unrealized loss on investments, net of tax (1,009)         (1,009)      
Ending balance (in shares) at Sep. 30, 2021     162,424,440            
Ending balance at Sep. 30, 2021 $ 4,582,445   $ 1,647 3,789,623   (53,726) (251,257) 1,096,158  
Beginning balance (in shares) at Dec. 31, 2021 160,512,111   160,512,111            
Beginning balance at Dec. 31, 2021 $ 4,530,014 $ (235,427) $ 1,605 3,340,822 $ (375,414) (69,105) 0 1,256,692 $ 139,987
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     1,376,712            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (72,770)   $ 14 (72,784)          
Issuance of common stock under employee stock purchase plan (in shares)     335,644            
Issuance of common stock under employee stock purchase plan 29,308   $ 3 29,305          
Stock-based compensation 183,041     183,041          
Repurchases of common stock (in shares)     (4,347,856)            
Repurchases of common stock (430,269)           (430,269)    
Net income 346,854             346,854  
Foreign currency translation adjustments (86,321)         (86,321)      
Change in unrealized loss on investments, net of tax $ (31,246)         (31,246)      
Ending balance (in shares) at Sep. 30, 2022 157,876,611   157,876,611            
Ending balance at Sep. 30, 2022 $ 4,233,184   $ 1,622 3,104,970   (186,672) (430,269) 1,743,533  
Beginning balance (in shares) at Jun. 30, 2022     159,469,828            
Beginning balance at Jun. 30, 2022 4,280,478   $ 1,620 3,054,200   (143,079) (267,642) 1,635,379  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     195,331            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (8,242)   $ 2 (8,244)          
Stock-based compensation 59,014     59,014          
Repurchases of common stock (in shares)     (1,788,548)            
Repurchases of common stock (162,627)           (162,627)    
Net income 108,154             108,154  
Foreign currency translation adjustments (39,079)         (39,079)      
Change in unrealized loss on investments, net of tax $ (4,514)         (4,514)      
Ending balance (in shares) at Sep. 30, 2022 157,876,611   157,876,611            
Ending balance at Sep. 30, 2022 $ 4,233,184   $ 1,622 $ 3,104,970   $ (186,672) $ (430,269) $ 1,743,533